Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COOL-SED: Dexmedetomidine vs Morphine in Neonatal HIE
NCT06985290Phase 2Not yet recruiting
- Start
- Jul 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in hypoxic-ischemic encephalopathy (HIE). Planned start Jul 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT06985290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06985290.